Tags: Drug.

BMS-470539 is a synthetic small molecule drug which acts as a potent and highly selective full agonist of the MC1 receptor. It was discovered in 2003 as part of an effort to understand the role of the MC1 receptor in immunomodulation and has since been used in scientific research to determine its role in inflammatory processes.

BMS_470539.svg
ATC prefix
None
Bioavailability
100.0
CAS number
457893-92-4
IUPAC name
(2S)-2-amino-N-[(1R)-2-(4-butanoyl-4-phenyl-1-piperidyl)-1-[(4-methoxyphenyl)methyl]-2-oxo-ethyl]-3-(3-methylimidazol-4-yl)propanamide dihydrochloride

Loading...

This page contains content from the copyrighted Wikipedia article "BMS-470539"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.